• SHARE

The U.S. Food and Drug Administration’s decision to recommend a pause in distribution of the Johnson & Johnson COVID-19 vaccine has been roundly — and rightly — condemned across the political spectrum. It’s clear that the hypersensitive “abundance of caution” standard the FDA applied is inappropriate for a global pandemic.

Less well recognized is that the same standard, applied during normal times, also has enormous costs for lives and health of Americans.

In a time of both misinformation and too much information, quality journalism is more crucial than ever.
By subscribing, you can help us get the story right.

SUBSCRIBE NOW

PHOTO GALLERY (CLICK TO ENLARGE)